20/20 Biolabs, Inc. (AIDX)
0.5139
-0.04
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
0.5139
0.00 (0.00%)
After-Hours: 20:00
20/20 Biolabs Total Assets (Quarterly) : 6.123M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.123M |
| March 31, 2026 | 5.803M |
| December 31, 2025 | 4.137M |
| September 30, 2025 | 3.239M |
| March 31, 2025 |
| Date | Value |
|---|---|
| December 31, 2024 | 3.613M |
| September 30, 2024 | |
| June 30, 2023 | 8.831M |
| March 31, 2023 | 10.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 69.15M |
| Intelligent Bio Solutions, Inc. | 12.28M |
| Anteris Technologies Global Corp. | 272.51M |
| Quest Diagnostics, Inc. | 16.94B |
| Labcorp Holdings, Inc. | 18.53B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.964M |
| Shareholders Equity (Quarterly) | 3.159M |
| Debt to Equity Ratio | 0.1812 |
| Current Ratio | 1.990 |
| Net Debt Paydown Yield | 0.79% |